Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
about
Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancerAldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell linePhenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancerAldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cellsAldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer.Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancerALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysisRetroviral-infection increases tumorigenic potential of MDA-MB-231 breast carcinoma cells by expanding an aldehyde dehydrogenase (ALDH1) positive stem-cell like populationAldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cellsExpression of ALDH1 and TGFβ2 in benign and malignant breast tumors and their prognostic implicationsAge determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.Deconstructing the molecular portraits of breast cancer.ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinomaCirculating tumor cells: from bench to bedsideCD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer.Histological, molecular and functional subtypes of breast cancersNucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineImmunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancerCancer stem cells, cancer cell plasticity and radiation therapyBasal-like and triple-negative breast cancers: searching for positives among many negativesExpression of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa co-determines the prognosis of colon cancer patients.EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development.An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.The role of breast cancer stem cells in metastasis and therapeutic implications.The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective studyCancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.Aldehyde dehydrogenase 1 expression correlates with clinicopathologic features of patients with breast cancer: a meta-analysisTargeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies.Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer.Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responsesUSP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancerExpression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.The absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer.
P2860
Q26861556-6782A352-E640-4DEA-8AF3-9AA71D285C9FQ28534236-EC3D2F65-80DD-463C-A6AA-B9074A53DEABQ29619481-4FA8A931-7DD5-444F-82AF-B9091C032A03Q33556557-9815495C-7EC7-45A6-A1D1-92053B34D961Q33621381-29F01104-F673-49A7-B9A9-345CFC828156Q33674656-E7859443-355B-4263-BA0A-7C92881D84CEQ33700204-48E8BFB2-F2B2-4FE8-9151-D87B66D7BF9AQ33739585-DC119966-4D1A-4C1F-84A2-5C182892B756Q33804523-C9409ED4-F4D2-42CF-86DC-79A5E8517551Q33857917-2722A90D-04EE-4FF0-AD05-B6DAD12F2F2EQ34026132-425A7222-A221-4759-B132-5B6AEAFC5818Q34029177-B2A6E1C0-025E-42BC-AFE2-B8EE9662FDD6Q34142021-F214B43F-6583-4B01-9F4E-BA65DAE44FBCQ34154147-E02C0DA9-9D3A-402D-965E-236D452775EFQ34293491-E1A0412F-ECA7-41B1-B6F1-836FCF71F0C3Q34307782-93E68BF0-FEF8-4664-8844-1F56CFB07347Q34438511-83C244BF-411E-4617-A278-240CCFB8F258Q34616569-DFD4A627-9DE9-4214-B438-A0BC1D7CE051Q34698624-BFB51A40-07B1-4729-BEFB-0E098D001568Q34731134-D5C940AB-BABE-4872-9EEC-E90D3DE8A474Q34921599-78A144E5-F79B-47E3-B2B6-17D50497948AQ35005793-75E13B39-4743-4B6F-8584-EA22428A6A8BQ35014814-5195BFEB-C176-4C67-A3FE-6C23A089D626Q35019505-87F7EB1D-0A53-4EEC-B5D4-D0F87FAF9954Q35034623-1D8C2DDF-8CEB-4E75-9EE6-70257E4A0AB1Q35048136-86D94648-0989-4595-A766-AC436322E025Q35070157-9FCAED7F-02B7-4562-92FB-C8969A6FF3A7Q35684532-A3B1B7E6-12CC-49F9-A3F2-AD9B7E0EBF5AQ35889609-202D866F-7F6B-43D4-B140-F259B025C894Q35958671-9189B36D-15C3-4C08-BCA4-D0F676C6B550Q36104984-26F1C9D0-C711-45F7-95F8-BBFD0C83048DQ36184940-FAB4F8E8-35FB-499B-8398-6C8D6E0AA8ABQ36405638-023D88C7-8DBD-4332-800D-6C00CB34779AQ36413616-0CFBF684-CFEB-48D8-A9C6-F4AACC7A515BQ36441530-D79EE87C-AE35-4B9F-B054-A7DDEB1FB763Q36562382-9E362142-5CF6-4419-A3B6-E1F7CE6B98EFQ36586333-ED22B331-AADA-4028-8D3A-FB83E67D703BQ36599308-38C95FE3-3BD9-4235-AF60-5DAE3820103DQ36958447-EB34634A-FB60-4158-9AA8-97C9D199109BQ36961467-A75B75D8-A65B-4B15-AEC8-9814AE8C5602
P2860
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Prognostic impact of ALDH1 in ...... ls and tumor microenvironment.
@en
Prognostic impact of ALDH1 in ...... ls and tumor microenvironment.
@nl
type
label
Prognostic impact of ALDH1 in ...... ls and tumor microenvironment.
@en
Prognostic impact of ALDH1 in ...... ls and tumor microenvironment.
@nl
prefLabel
Prognostic impact of ALDH1 in ...... ls and tumor microenvironment.
@en
Prognostic impact of ALDH1 in ...... ls and tumor microenvironment.
@nl
P2093
P50
P1476
Prognostic impact of ALDH1 in ...... lls and tumor microenvironment
@en
P2093
Erika Resetkova
Jorge S Reis-Filho
Rohit K Jain
Sunil Badve
P2888
P304
P356
10.1007/S10549-009-0619-3
P407
P577
2009-11-13T00:00:00Z
P6179
1026582657